Keywords: Almirall, Forest Labs, LAS100977, Research, Licensing, COPD

Almirall and Forest Labs to expand LAS100977 respiratory deal with $75 million upfront

Article | 17 December 2009

Print This

Spain’s largest drugmaker Almirall and the USA’s Forest Laboratories have entered into a second accord, signing an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in